The aim of the CARPE registry is to investigate characteristics and medical care in patients affected by chronic hand eczema. Patients are assessed by dermatological examination and patient questionnaire. Socio-economic and clinical data are collected, and quality of life is measured using the Dermatology Life Quality Index (DLQI). A total of 1,163 patients with chronic hand eczema were eligible for analysis (mean age 47.0 years; 54.6% female; mean disease duration 7.6 years). At inclusion, chronic hand eczema was very severe in 23.4%, severe in 47.0%, moderate in 20.1%, and clear or almost clear in 9.6% of patients. Median DLQI was 8.0. In all, 93.8% of patients reported use of topical corticosteroids, 25.6% systemic antihistamines, 28.3% topical calcineurin-inhibitors, 38.0% ultraviolet phototherapy, and 35.3% systemic treatment (19.7% alitretinoin) prior to inclusion in the registry. A significant proportion of patients may not receive adequate treatment according to the guideline on management of hand eczema. © 2014 The Authors.
CITATION STYLE
Apfelbacher, C. J., Molin, S., Weisshaar, E., Bauer, A., Elsner, P., Mahler, V., … Diepgen, T. L. (2014). Characteristics and provision of care in patients with chronic hand eczema: Updated data from the CARPE registry. Acta Dermato-Venereologica, 94(2), 163–167. https://doi.org/10.2340/00015555-1632
Mendeley helps you to discover research relevant for your work.